Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Clinical Trials

4 clinical trials for Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma — RECRUITING · PHASE2
• Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma — RECRUITING · PHASE1
• Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy — RECRUITING · PHASE2
• Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search